The eleventh batch of the Group Purchasing Organization (GPO) of the pharmaceutical industry in Mainland China has recently been initiated, Shi Zihai, Deputy Director of the National Healthcare Security Administration (NHSA), stated at a press conference. The NHSA is researching to optimize specific rules, particularly in the selection rules, by refining the calculation "anchor point" for price differences. The lowest bid will no longer be simply taken as a reference. Related NewsCiti Elevates WUXI APPTEC (02359.HK) TP to $130, Raises Earnings ForecastsMeanwhile, for the selected company with the lowest bid, it must publicly explain the reasonableness of its bid and commit not to bid below cost.